A multidisciplinary approach utilizing TEG and recombinant factors can safely manage the high perioperative bleeding risk in patients with Glanzmann's thrombasthenia undergoing cardiac surgery.
Hypothesis-generating for Glanzmann's thrombasthenia cardiac surgery; prospective validation required before practice change.
Patients with GT requiring cardiac surgical procedures are at high risk for perioperative bleeding complications. This case report illustrates the importance of multidisciplinary planning, TEG analysis, and the judicious use of recombinant factors to minimize operative bleeding risk.
No takes yet. Share an insight, caveat, or question.
Sheikh et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: